SCHEMBL19939293

SCHEMBL19939293

CC(C)c1ccc(OCCS)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.44
KDM4E B2RXH2 4/20 0.41
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
HTT P42858 1/20 0.38
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
RECQL P46063 1/20 0.36
PDE2A O00408 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
GPR88 Q9GZN0 1/20 0.33
FFAR1 O14842 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15000540 0.85 CARM1 (0.49) CARM1KDM4EKMT2AMEN1LMNA
SCHEMBL19618909 0.85 CARM1 (0.52) CARM1KDM4EKMT2AMEN1HTT
SCHEMBL22857118 0.85 CARM1 (0.46) CARM1KDM4EKMT2AMEN1HTT
SCHEMBL16997126 0.83 TDP1 (0.50) CARM1KDM4EKMT2AMEN1HTT
SCHEMBL8221290 0.83 CARM1 (0.44) CARM1KDM4EKMT2AMEN1HTT
SCHEMBL8226478 0.83 CARM1 (0.44) CARM1KDM4EKMT2AMEN1HTT
SCHEMBL18119645 0.82 NQO1 (0.48) CARM1KDM4EKMT2AMEN1HTT
SCHEMBL15000514 0.82 CARM1 (0.47) CARM1KDM4ECYP1A2CYP2C19CYP2C9
SCHEMBL15000473 0.81 NR5A1 (0.47) CARM1KDM4ECYP1A2CYP2C19CYP3A4
SCHEMBL19618878 0.81 CARM1 (0.52) CARM1KDM4ELMNAL3MBTL1ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10294223-B2 Quinolone derivatives as fibroblast growth factor receptor inhibitors PRINCIPIA BIOPHARMA, INC. (US) 2019-05-21 US disclosed
US-20180065960-A1 QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS PRINCIPIA BIOPHARMA INC. 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10294223-B2 Quinolone derivatives as fibroblast growth factor receptor inhibitors FGFR1, FGFR3, FGFR2 CARM1 4595/4885KDM4E 2775/4885KMT2A 3486/4885
US-20180065960-A1 QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS FGFR1, FGFR3, FGFR2 CARM1 4595/4885KDM4E 2775/4885KMT2A 3486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.